GOODWILL AND INTANGIBLE ASSETS

6 Months Ended

Jun. 30, 2013

NOTE 2: GOODWILL AND INTANGIBLE ASSETS

The change in the carrying amount of goodwill for the six months ended June 30, 2013 was as follows:

	Technology Segment			Bankruptcy and Settlement Administration Segment		Total
	(in thousands)
Balance as of December 31, 2012	$	189,248		$	214,963	$	404,211
Foreign currency translation	(267		)	—		(267		)
Balance as of June 30, 2013	$	188,981		$	214,963	$	403,944

Identifiable intangible assets as of June 30, 2013 and December 31, 2012 consisted of the following:

	June 30, 2013				December 31, 2012
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
	(in thousands)
Amortizing intangible assets:
Customer relationships	$	124,512	$	82,151	$	124,512	$	73,713
Trade names	6,591		2,062		6,591		1,650
Non-compete agreements	18,947		15,588		18,947		14,736
Total	$	150,050	$	99,801	$	150,050	$	90,099

Customer relationships, trade names, and non-compete agreements carry a weighted average life of seven years, eight years, and five years, respectively.

Amortization expense related to identifiable intangible assets was $4.7 million and $6.8 million for the three months ended June 30, 2013 and 2012, respectively, and $9.7 million and $13.5 million for the six months ended June 30, 2013 and 2012, respectively. The following table outlines the estimated future amortization expense related to intangible assets at June 30, 2013:

(in thousands)
Year Ending December 31,
2013 (from July 1, 2013 to December 31, 2013)	$	9,132
2014	12,569
2015	9,893
2016	6,232
2017	5,390
2018 and thereafter	7,033
Total	$	50,249

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details